NCT06387290 Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
| NCT ID | NCT06387290 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | University of Utah |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2028-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 300 participants in total. It began in 2025-02-25 with a primary completion date of 2028-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this implementation-effectiveness trial is to examine the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care as interventions to reduce chronic pain, improve quality of life, and reduce opioid-related harms among chronic pain patients on long-term opioid therapy.
Eligibility Criteria
Inclusion Criteria: * Age 18 + * Current chronic pain diagnosis (pain for ≥3 months) determined by physician assessment * Prescribed long-term opioid therapy (≥3 months) * Score \>=3 on the Pain Enjoyment General Activity scale * Score \>=9 on the Current Opioid Misuse Measure OR lifetime psychiatric or substance use disorder diagnosis OR benzodiazepine use OR history of overdose OR patient or physician determination that risks of opioid use may outweigh the benefits of opioid use Exclusion Criteria: * Chronic pain due to a cancer diagnosis * Active suicidal intent, schizophrenia, psychotic disorder * Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, Mindfulness-Based Relapse Prevention, or Mindfulness-Oriented Recovery Enhancement
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06387290 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06387290 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 300 participants.
Is NCT06387290 currently recruiting?
Yes, NCT06387290 is actively recruiting participants. Contact the research team at hapfeffer@health.ucsd.edu for enrollment information.
Where is the NCT06387290 trial being conducted?
This trial is being conducted at La Jolla, United States, New Brunswick, United States, Salt Lake City, United States.
Who is sponsoring the NCT06387290 clinical trial?
NCT06387290 is sponsored by University of Utah. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.